Award recordCONTRACT

ACORDA THERAPEUTICS, INC.

PIID 36C77022N0095· VHA· NATIONAL CMOP OFFICE (36C770)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $211,951 net obligations· UEI R5D3FUPFFPK4· NY

Description

LEVODOPA INHALATION POWDER 42MG CAPSULES, 60/BOX, QTY 144 BOXES

First action · last action
2022-03-16 · 2022-05-11
Transactions
2
First transaction's obligation
$105,975
Base + all options value (sum of deltas)
$211,951
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0361
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$211,951$0Base award · 2022-03-16 · this action $105,975 · running total $105,975Modification P00001 · 2022-05-11 · this action $105,975 · running total $211,951
  • Base2022-03-16+$105,975= $105,975
  • Mod P000012022-05-11+$105,975= $211,951
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-03-16+$105,975$105,975LEVODOPA INHALATION POWDER 42MG CAPSULES, 60/BOX, QTY 144 BOXES
Mod P00001· EXERCISE AN OPTION2022-05-11+$105,975$211,951LEVODOPA INHALATION POWDER 42MG CAPSULES, 60/BOX, QTY 144 BOXES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI R5D3FUPFFPK4)

AwardOffice · PSC / listingNet obligationsFY
36C77024N0067NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$493,607FY2024
36E79724A0005NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C77024N0027NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$444,505FY2024
36F79723D0194NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79723A0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C77023N0057NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$529,877FY2023

Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C77026P0118HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$30,935FY2026
36C77026P0129DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$76,656FY2026
36C77026P0127DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$58,395FY2026
36C77026P0086SAGENT PHARMACEUTICALS, INCNATIONAL CMOP OFFICE (36C770)$275,580FY2026
36C77026P0095HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$83,520FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77022N0095_3600_36F79718D0361_3600 · retrieved 2026-09-26.